| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000025906 |
| Receipt No. | R000029782 |
| Scientific Title | Effectiveness and feasibility of a disease management program strengthening good sleep and activities in people with diabetic nephropathy: A pilot study |
| Date of disclosure of the study information | 2017/01/31 |
| Last modified on | 2021/10/19 (Ver. 18) |
| Basic information | ||
| Public title | Effectiveness and feasibility of a disease management program strengthening good sleep and activities in people with diabetic nephropathy: A pilot study | |
| Acronym | The study of effects on a diabetic nephropathy disease management program strengthening sleep and activities | |
| Scientific Title | Effectiveness and feasibility of a disease management program strengthening good sleep and activities in people with diabetic nephropathy: A pilot study | |
| Scientific Title:Acronym | The study of effects on a diabetic nephropathy disease management program strengthening sleep and activities | |
| Region |
|
|
| Condition | |||
| Condition | Type 2 Diabetic nephropathy | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | We carry out the program for strengthening good sleep and activities based on the previously developed disease management program for people with diabetic nephropathy and evaluate effectiveness of the improvement of diabetic nephropathy and the feasibility of the program. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 1. Physiological indicators: Weight (BMI), blood pressure, pulse rate, fasting blood glucose, HbA1c, urine protein/urine albumin, serum creatinine (eGFR), nonHDL-cholesterol, triglycerides
2. Change of the diabetic nephropathy stage 3. Onset and progression of diabetic complication and disease 4. Amount of activity 5. Sleep difficulties (description, scale scores) 6. SpO2 7. QOL 8. Feasibility: participation rate, completion rate, use of equipments and fitness, evaluation of the program, etc) 9. Behavioral indicators: quality of activities, behavior change/self-monitoring 10. Presenteeism and absennteeism |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Educational,Counseling,Training | |
| Type of intervention |
|
|
| Interventions/Control_1 | Implementation of a diabetic nephropathy disease management program (acquisition of self-management skills and lifestyle change, 6 month-period, combination of face-to-face interview and telephone call); Assess problems on sleep and advice coping strategies if he/she has; Recommend going to the fitness club (1/week, 12 times), assess activities and advice appropriate activities | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Type 2 diabetic nephropathy patients at Stages 1-3 according to the diabetic guideline
1. Beneficiaries of Hiroshima-city National Health Insurance and Union National Health Insurance living in Hiroshima prefecture, and the insured of Japan Health Insurance Association, Hiroshima chapter, and National Federation of Health Insurance Societies of Hiroshima. 2. A patient was judged by his/her general physician or physician in charge of diabetic care intended to participate in this study 3. An outpatient in diabetic treatment 4. Age =>20 and =<74 years old of both sexes 5. Not participate in another clinical study 6. A patient whom can receive a written consent form Do not consider who takes sleeping drugs and/or psychotropic drugs. |
|||
| Key exclusion criteria | 1. A patient was judged by the nurses (who provide the program) as unable to implement the program (such as difficulties in visiting the education site, filling in questionnaires, and measuring the sleep scale and activities by his/herself)
2. An inpatient 3. A patient at Renal Replacement Therapy (RRT) 4. A patient who has a plan for renal transplantation within 6 months 5. A patient at end stage 6. Type 1 diabetes and in case of secondary diabetes 7. Pregnant women 8. Dementia 9. Those who have behavioral problems and be considered as difficult to continue the program by his/her general physician, physician in charge of diabetic care or researcher |
|||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Graduate School of Biomedical and Health Sciences, Hiroshima University | ||||||
| Division name | Division of Nursing Science | ||||||
| Zip code | 734-8553 | ||||||
| Address | Hiroshima | ||||||
| TEL | 082-257-5365 | ||||||
| morimich@hiroshima-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Graduate School of Biomedical and Health Sciences, Hiroshima University | ||||||
| Division name | Division of Nursing Science | ||||||
| Zip code | 734-8553 | ||||||
| Address | Hiroshima | ||||||
| TEL | 082-257-5365 | ||||||
| Homepage URL | |||||||
| morimich@hiroshima-u.ac.jp | |||||||
| Sponsor | |
| Institute | Division of Nursing Science, Graduate School of Biomedical and Health Sciences, Hiroshima University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Grants-in-Aid for Scientific Research
Hiroshima Prefecture (until March 2017) |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Hiroshima Prefecture, Hiroshima City |
| Name of secondary funder(s) | Hiroshima Prefecture |
| IRB Contact (For public release) | |
| Organization | Hiroshima University Research Ethics Committee |
| Address | Kasumi 1-2-3, Minami-ku |
| Tel | 082-257-1752 |
| protocol@cimr.hiroshima-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | doi: 10.1136/bmjopen-2020-045783 |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | doi: 10.1136/bmjopen-2020-045783 | ||||||
| Number of participants that the trial has enrolled | 26 | ||||||
| Results | For patients with diabetic nephropathy up to stage 3, the prevention program with enhanced sleep disorder and exercise was implemented, and statistically significant improvement was observed in BMI, HbA1c, non-HDL cholesterol, systolic blood pressure. The QOL scale, health condition score, self-management behavior were significantly improved. There was no improvement in the sleep state, but the recognition of the importance of sleep increased. We received positive evaluation from the patients. | ||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results |
|
||||||
| Baseline Characteristics | Of 26 patients, 17 were male (65.4%), and the mean age was 65.7 (SD 6.0) years. Of the 24 participants, 15(62.5%) were classified as having sleep disorders. | ||||||
| Participant flow | Twenty-nine participants were introduced. Among them, 26 met the eligibility criteria and were enrolled. Two participants dropped out right after enrolment. Therefore, only 24 participants completed the 6-month programme. | ||||||
| Adverse events | None | ||||||
| Outcome measures | To examine programme efficacy, baseline conditions were compared with outcomes during the 3rd and 6th months of intervention.
Physiological indicators (BMI, BP, eGFR, triglyceride, non-HDL, HbA1c), Number of steps per day, QOL, quality of sleep, behavior change |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029782 |